Yemaachi Biotechnology
Yemaachi Biotechnology develops precision cancer diagnostics and therapies to expand genomic representation and improve detection and treatment options. It uses immunogenomics, bioinformatics, and artificial intelligence to identify biomarkers and design targeted diagnostic assays and therapeutic approaches. The company operates as a B2B biotechnology and precision oncology provider serving research institutions, clinical laboratories, and healthcare organizations. Yemaachi emphasizes diversifying genomic datasets—particularly African populations—to create diagnostics and treatments applicable regionally and globally.
Yemaachi Biotechnology
Yemaachi Biotechnology develops precision cancer diagnostics and therapies to expand genomic representation and improve detection and treatment options. It uses immunogenomics, bioinformatics, and artificial intelligence to identify biomarkers and design targeted diagnostic assays and therapeutic approaches. The company operates as a B2B biotechnology and precision oncology provider serving research institutions, clinical laboratories, and healthcare organizations. Yemaachi emphasizes diversifying genomic datasets—particularly African populations—to create diagnostics and treatments applicable regionally and globally.